Zymeworks Announces FDA Clearance Of Investigational New Drug Application For ZW191
Zymeworks Announces FDA Clearance Of Investigational New Drug Application For ZW191 Zymeworks Announces FDA Clearance Of Investigational New Drug Application For ZW191, A Novel Folate Receptor Targeted Topoisomerase I Inhibitor Vancouver, BC, July 30, 2024 …